Lavipharm S.A. (ATH: LAVI)
Greece
· Delayed Price · Currency is EUR 0.737
-0.002 (-0.27%)
Dec 20, 2024, 5:09 PM EET
Lavipharm Market Cap
Lavipharm has a market cap or net worth of €124.33 million as of December 20, 2024. Its market cap has increased by 4.02% in one year.
Market Cap
124.33M
Enterprise Value
146.97M
Revenue
51.34M
Ranking
n/a
PE Ratio
17.42
Stock Price
€0.74
Market Cap Chart
Since October 21, 1996, Lavipharm's market cap has increased from 43.03M to 124.33M, an increase of 188.96%. That is a compound annual growth rate of 3.84%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Athens Medical C.S.A. | 134.44M |
| Eurobank Ergasias Services and Holdings S.A. | 8.22B |
| National Bank of Greece S.A. | 7.09B |
| Hellenic Telecommunications Organization S.A. | 6.01B |
| Organization of Football Prognostics S.A. | 5.64B |
| Piraeus Financial Holdings S.A. | 4.90B |
| Metlen Energy & Metals S.A. | 4.66B |
| Public Power Corporation S.A. | 4.10B |